PBAC Consultations

The Pharmaceutical Benefits Advisory Committee (PBAC) has 3 main cycles per year where it considers applications for funding of new medicines and vaccines. For most items on a meeting agenda, there is an 8-week consultation period.

Learn more about the PBAC and the Pharmaceutical Benefits Scheme (PBS).

Search and monitor the status of medicines that have been submitted to the PBAC on the Medicine Status Website.

Find a list of open consultations for items being considered by the PBAC.

Open PBAC consultations

Public consultation survey for the Rapid Review of PBS medicines for relapsing-remitting multiple sclerosis (RRMS) (December 2026 PBAC meeting)

Consultation is now open for the rapid review of Pharmaceutical Benefits Scheme (PBS) medicines for relapsing-remitting multiple sclerosis (RRMS). For further information on the review including...

Closes 1 October 2026

Public consultation on items to be considered by the PBAC (November 2026)

Consultation has opened for the November 2026 Pharmaceutical Benefits Advisory Committee (PBAC) agenda. The PBAC welcomes input from patients, carers, health professionals, consumer groups or...

Closes 16 September 2026

PBAC Updates

Subscribe to PBS.gov.au email notification of the Pharmaceutical Benefits Scheme (PBS) news, including PBAC meeting agendas, consultations and outcomes.

Sign up